Inactive

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure: CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies, on a sol... The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure: CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies, on a sole source basis. The Food and Drug Administration (FDA) intends to award this Sole Source purchase order to Fluigent, Inc., located at: Fluigent, Inc., 73 Princeton St., Suite 310, N. Chelmsford, MA 01863, Phone (978) 269-0347, Email: fluigentinc@fl uigent.com.